Comparison of Treatment Retention of Adults With Opioid Addiction Managed With Extended-Release Buprenorphine vs Daily Sublingual Buprenorphine-Naloxone at Time of Release From Jail

IMPORTANCE: Extended-release buprenorphine (XRB), a monthly injectable long-acting opioid use disorder (OUD) treatment, has not been studied for use in corrections facilities. OBJECTIVE: To compare treatment retention following release from jail among adults receiving daily sublingual buprenorphine-...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Joshua D., Malone, Mia, McDonald, Ryan, Cheng, Anna, Vasudevan, Kumar, Tofighi, Babak, Garment, Ann, Porter, Barbara, Goldfeld, Keith S., Matteo, Michael, Mangat, Jasdeep, Katyal, Monica, Giftos, Jonathan, MacDonald, Ross
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427378/
https://www.ncbi.nlm.nih.gov/pubmed/34495340
http://dx.doi.org/10.1001/jamanetworkopen.2021.23032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427378/
https://www.ncbi.nlm.nih.gov/pubmed/34495340
http://dx.doi.org/10.1001/jamanetworkopen.2021.23032

Ejemplares similares